Literature DB >> 23266069

Pattern recognition analysis of digital ECGs: decreased QT measurement error and improved precision compared to semi-automated methods.

Olivier Meyer1, Georg Ferber, Gerard Greig, Henry H Holzgrefe.   

Abstract

BACKGROUND AND
PURPOSE: Machine-read QT measurements employing T-wave detection algorithms (ALG) are not accepted by regulatory agencies for the primary analysis of thorough QT (TQT) studies. Newly developed pattern recognition software (PRO) which matches ECG waveforms to user-defined templates may improve this situation.
METHODS: We compared RR, QT, QTc, QT variability, T-end measurement errors, and individual QT rate correction factors and their associated coefficients of determination (R(2)) following ALG and PRO analysis. Machine-read QTc values were compared with core laboratory semi-automated (SA) values for verification.
RESULTS: Compared to ALG, PRO reduced the frequency of T-end measurement errors (5.6% vs. 0.1%), reduced the intra-individual QT variability (12.6±5.9 vs. 4.9±1.1ms) and allowed the recovery of 3/58 subjects that exhibited an unacceptable (<0.9) R(2).
CONCLUSIONS: PRO adjusted for ALG-based T-end measurement errors and provided an accurate and precise automated method for continuous QT analysis, thus offering an alternative to resource-intensive semi-automated analyses currently performed by ECG core laboratories.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23266069     DOI: 10.1016/j.jelectrocard.2012.11.012

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Impact of electrocardiographic data quality on moxifloxacin response in thorough QT/QTc studies.

Authors:  Lars Johannesen; Christine Garnett; Marek Malik
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

2.  Electrocardiographic data quality in thorough QT/QTc studies.

Authors:  Lars Johannesen; Christine Garnett; Marek Malik
Journal:  Drug Saf       Date:  2014-03       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.